The study was funded by the U.S. National Institutes of Health. Lin is a consultant to Pfizer, which is developing a potential drug for age-related hearing loss, and has served as an unpaid speaker for Cochlear Europe, which makes cochlear implants to treat severe hearing loss.
More information
Learn more about hearing loss from the U.S. National Institute on Deafness and Other Communication Disorders.
Copyright © 2012 HealthDay. All rights reserved.
Reader Comments (